{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:58:09Z","timestamp":1776578289082,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Melatonin (MT), a neurohormone with immunomodulatory properties, is one of the metabolites produced in the brain from tryptophan (TRP) that has already strong links with the neuropathogenesis of Multiple sclerosis (MS). However, the exact molecular mechanisms behind that are not fully understood. There is some evidence showing that MS and MT are interconnected via different pathways: Relapses of MS has a direct correlation with a low level of MT secretion and a growing body of evidence suggest that MT be therapeutic in Experimental Autoimmune Encephalomyelitis (EAE, a recognise animal model of MS) severity. Previous studies have demonstrated that the kynurenine pathway (KP), the main pathway of TRP catabolism, plays a key role in the pathogenesis of MS in humans and in EAE. The present study aimed to investigate whether MT can improve clinical signs in the EAE model by modulating the KP. C57BL\/6 mice were induced with EAE and received different doses of MT. Then the onset and severity of EAE clinical symptoms were recorded. Two biological factors, aryl hydrocarbon receptor (AhR) and NAD<jats:sup>+<\/jats:sup> which closely interact in the KP were also assessed. The results indicated that MT treatment at all tested doses significantly decrease the EAE clinical scores and the number of demyelinating plaques. Furthermore, MT treatment reduced the mRNA expression of the KP regulatory enzyme indoleamine 2,3-dioxygenase 1(IDO-1) and other KP enzymes. We also found that MT treatment reduces the mRNA expression of the AhR and inhibits the enzyme Nicotinamide N-Methyltransferase (Nnmt) overexpression leading to an increase in NAD<jats:sup>+<\/jats:sup>\u2009levels. Collectively, this study suggests that MT treatment may significantly attenuates the severity of EAE by altering the KP, AhR and NAD<jats:sup>+<\/jats:sup> metabolism.<\/jats:p>","DOI":"10.1038\/s41598-022-20164-0","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T15:15:58Z","timestamp":1664032558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway"],"prefix":"10.1038","volume":"12","author":[{"given":"Yahya","family":"Jand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Ghahremani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Ejtemaei-Mehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Ghazi-Khansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"key":"20164_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222 (2022).","journal-title":"Science"},{"key":"20164_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fphar.2019.00147","volume":"10","author":"M Ghareghani","year":"2019","unstructured":"Ghareghani, M. et al. Melatonin therapy modulates cerebral metabolism and enhances remyelination by increasing PDK4 in a mouse model of multiple sclerosis. Front. Pharmacol. 10, 147. https:\/\/doi.org\/10.3389\/fphar.2019.00147 (2019).","journal-title":"Front. Pharmacol."},{"key":"20164_CR3","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 269\u2013285. https:\/\/doi.org\/10.1016\/s1474-4422(18)30443-5 (2019).","DOI":"10.1016\/s1474-4422(18)30443-5"},{"key":"20164_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","volume":"26","author":"A Bar-Or","year":"2020","unstructured":"Bar-Or, A. et al. Epstein-Barr virus in multiple sclerosis: Theory and emerging immunotherapies. Trends Mol. Med. 26, 296\u2013310. https:\/\/doi.org\/10.1016\/j.molmed.2019.11.003 (2020).","journal-title":"Trends Mol. Med."},{"key":"20164_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059749","volume":"8","author":"W Wu","year":"2013","unstructured":"Wu, W. et al. Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer\u2019s disease brain. PLoS ONE 8, e59749. https:\/\/doi.org\/10.1371\/journal.pone.0059749 (2013).","journal-title":"PLoS ONE"},{"key":"20164_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","volume":"7","author":"MD Lovelace","year":"2016","unstructured":"Lovelace, M. D. et al. Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis. Front. Immunol. 7, 246. https:\/\/doi.org\/10.3389\/fimmu.2016.00246 (2016).","journal-title":"Front. Immunol."},{"key":"20164_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3389\/fnins.2019.01013","volume":"13","author":"VX Tan","year":"2019","unstructured":"Tan, V. X. & Guillemin, G. J. Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis. Front Neurosci. 13, 1013. https:\/\/doi.org\/10.3389\/fnins.2019.01013 (2019).","journal-title":"Front Neurosci."},{"key":"20164_CR8","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1038\/s41467-019-12776-4","volume":"10","author":"JK Sonner","year":"2019","unstructured":"Sonner, J. K. et al. Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology. Nat. Commun. 10, 4877. https:\/\/doi.org\/10.1038\/s41467-019-12776-4 (2019).","journal-title":"Nat. Commun."},{"key":"20164_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/jnnp.42.7.640","volume":"42","author":"F Monaco","year":"1979","unstructured":"Monaco, F., Fumero, S., Mondino, A. & Mutani, R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. J. Neurol. Neurosurg. Psychiatry 42, 640\u2013641. https:\/\/doi.org\/10.1136\/jnnp.42.7.640 (1979).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"20164_CR10","doi-asserted-by":"publisher","first-page":"41473","DOI":"10.1038\/srep41473","volume":"7","author":"CK Lim","year":"2017","unstructured":"Lim, C. K. et al. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci. Rep. 7, 41473. https:\/\/doi.org\/10.1038\/srep41473 (2017).","journal-title":"Sci. Rep."},{"key":"20164_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12974-020-01844-y","volume":"17","author":"G Sundaram","year":"2020","unstructured":"Sundaram, G., Lim, C. K., Brew, B. J. & Guillemin, G. J. Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression. J. Neuroinflamm. 17, 176. https:\/\/doi.org\/10.1186\/s12974-020-01844-y (2020).","journal-title":"J. Neuroinflamm."},{"key":"20164_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0404.2005.00442.x","volume":"112","author":"Z Hartai","year":"2005","unstructured":"Hartai, Z. et al. Kynurenine metabolism in multiple sclerosis. Acta Neurol. Scand. 112, 93\u201396. https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00442.x (2005).","journal-title":"Acta Neurol. Scand."},{"key":"20164_CR13","doi-asserted-by":"publisher","first-page":"41271","DOI":"10.1038\/srep41271","volume":"7","author":"TV Lanz","year":"2017","unstructured":"Lanz, T. V. et al. Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis. Sci. Rep. 7, 41271. https:\/\/doi.org\/10.1038\/srep41271 (2017).","journal-title":"Sci. Rep."},{"key":"20164_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41419-019-1556-7","volume":"10","author":"A Tarocco","year":"2019","unstructured":"Tarocco, A. et al. Melatonin as a master regulator of cell death and inflammation: Molecular mechanisms and clinical implications for newborn care. Cell Death Dis. 10, 317. https:\/\/doi.org\/10.1038\/s41419-019-1556-7 (2019).","journal-title":"Cell Death Dis."},{"key":"20164_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/bies.201600018","volume":"38","author":"MF Farez","year":"2016","unstructured":"Farez, M. F., Calandri, I. L., Correale, J. & Quintana, F. J. Anti-inflammatory effects of melatonin in multiple sclerosis. BioEssays News Rev. Mol. Cell. Dev. Biol. 38, 1016\u20131026. https:\/\/doi.org\/10.1002\/bies.201600018 (2016).","journal-title":"BioEssays News Rev. Mol. Cell. Dev. Biol."},{"key":"20164_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1203\/PDR.0b013e3181fcb40b","volume":"69","author":"S Villapol","year":"2011","unstructured":"Villapol, S. et al. Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke. Pediatr. Res. 69, 51\u201355. https:\/\/doi.org\/10.1203\/PDR.0b013e3181fcb40b (2011).","journal-title":"Pediatr. Res."},{"key":"20164_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1269\/jrr.06070","volume":"48","author":"A Shirazi","year":"2007","unstructured":"Shirazi, A., Ghobadi, G. & Ghazi-Khansari, M. A radiobiological review on melatonin: A novel radioprotector. J. Radiat. Res. 48, 263\u2013272. https:\/\/doi.org\/10.1269\/jrr.06070 (2007).","journal-title":"J. Radiat. Res."},{"key":"20164_CR18","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.3389\/fimmu.2018.02484","volume":"9","author":"M Ghareghani","year":"2018","unstructured":"Ghareghani, M., Reiter, R. J., Zibara, K. & Farhadi, N. Latitude, vitamin D, melatonin, and gut microbiota act in concert to initiate multiple sclerosis: A new mechanistic pathway. Front. Immunol. 9, 2484. https:\/\/doi.org\/10.3389\/fimmu.2018.02484 (2018).","journal-title":"Front. Immunol."},{"key":"20164_CR19","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cell.2015.08.025","volume":"162","author":"MF Farez","year":"2015","unstructured":"Farez, M. F. et al. Melatonin contributes to the seasonality of multiple sclerosis relapses. Cell 162, 1338\u20131352. https:\/\/doi.org\/10.1016\/j.cell.2015.08.025 (2015).","journal-title":"Cell"},{"key":"20164_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103520","volume":"58","author":"BM Escribano","year":"2022","unstructured":"Escribano, B. M. et al. Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Mult. Scler. Relat. Disord. 58, 103520. https:\/\/doi.org\/10.1016\/j.msard.2022.103520 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"20164_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nrl.2018.01.007","volume":"36","author":"EJ Ramos Gonz\u00e1lez","year":"2021","unstructured":"Ramos Gonz\u00e1lez, E. J. et al. A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis. Neurologia (Engl Ed) 36, 262\u2013270. https:\/\/doi.org\/10.1016\/j.nrl.2018.01.007 (2021).","journal-title":"Neurologia (Engl Ed)"},{"key":"20164_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbi.2015.06.021","volume":"50","author":"N \u00c1lvarez-S\u00e1nchez","year":"2015","unstructured":"\u00c1lvarez-S\u00e1nchez, N. et al. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector\/regulatory balance. Brain Behav. Immun. 50, 101\u2013114. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.021 (2015).","journal-title":"Brain Behav. Immun."},{"key":"20164_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.703532","volume":"8","author":"EL Hopkins","year":"2021","unstructured":"Hopkins, E. L., Gu, W., Kobe, B. & Coleman, M. P. A novel NAD signaling mechanism in axon degeneration and its relationship to innate immunity. Front. Mol. Biosci. 8, 703532. https:\/\/doi.org\/10.3389\/fmolb.2021.703532 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"20164_CR24","doi-asserted-by":"publisher","first-page":"9794","DOI":"10.1523\/jneurosci.2116-06.2006","volume":"26","author":"S Kaneko","year":"2006","unstructured":"Kaneko, S. et al. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci. 26, 9794\u20139804. https:\/\/doi.org\/10.1523\/jneurosci.2116-06.2006 (2006).","journal-title":"J. Neurosci."},{"key":"20164_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2353\/ajpath.2007.060683","volume":"170","author":"I Tsunoda","year":"2007","unstructured":"Tsunoda, I., Tanaka, T., Terry, E. J. & Fujinami, R. S. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?. Am. J. Pathol. 170, 214\u2013226. https:\/\/doi.org\/10.2353\/ajpath.2007.060683 (2007).","journal-title":"Am. J. Pathol."},{"key":"20164_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.brainres.2013.08.025","volume":"1537","author":"N Braidy","year":"2013","unstructured":"Braidy, N., Lim, C. K., Grant, R., Brew, B. J. & Guillemin, G. J. Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis. Brain Res. 1537, 267\u2013272. https:\/\/doi.org\/10.1016\/j.brainres.2013.08.025 (2013).","journal-title":"Brain Res."},{"key":"20164_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107092","volume":"90","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome. Int. Immunopharmacol. 90, 107092. https:\/\/doi.org\/10.1016\/j.intimp.2020.107092 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"20164_CR28","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3389\/fimmu.2018.01914","volume":"9","author":"ACR Moreno","year":"2018","unstructured":"Moreno, A. C. R. et al. The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors. Front. Immunol. 9, 1914. https:\/\/doi.org\/10.3389\/fimmu.2018.01914 (2018).","journal-title":"Front. Immunol."},{"key":"20164_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-018-0255-3","volume":"20","author":"PS Minhas","year":"2019","unstructured":"Minhas, P. S. et al. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nat. Immunol. 20, 50\u201363. https:\/\/doi.org\/10.1038\/s41590-018-0255-3 (2019).","journal-title":"Nat. Immunol."},{"key":"20164_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-079x.1997.tb00330.x","volume":"23","author":"HA Walsh","year":"1997","unstructured":"Walsh, H. A. & Daya, S. Inhibition of hepatic tryptophan-2,3-dioxygenase: Superior potency of melatonin over serotonin. J. Pineal. Res. 23, 20\u201323. https:\/\/doi.org\/10.1111\/j.1600-079x.1997.tb00330.x (1997).","journal-title":"J. Pineal. Res."},{"key":"20164_CR31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00109-007-0229-7","volume":"85","author":"E Kwidzinski","year":"2007","unstructured":"Kwidzinski, E. & Bechmann, I. IDO expression in the brain: A double-edged sword. J. Mol. Med. (Berl) 85, 1351\u20131359. https:\/\/doi.org\/10.1007\/s00109-007-0229-7 (2007).","journal-title":"J. Mol. Med. (Berl)"},{"key":"20164_CR32","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/eji.200939535","volume":"39","author":"SK Schmidt","year":"2009","unstructured":"Schmidt, S. K. et al. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase. Eur. J. Immunol. 39, 2755\u20132764. https:\/\/doi.org\/10.1002\/eji.200939535 (2009).","journal-title":"Eur. J. Immunol."},{"key":"20164_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061564","author":"T Biernacki","year":"2020","unstructured":"Biernacki, T., Sandi, D., Bencsik, K. & V\u00e9csei, L. Kynurenines in the pathogenesis of multiple sclerosis: Therapeutic perspectives. Cells https:\/\/doi.org\/10.3390\/cells9061564 (2020).","journal-title":"Cells"},{"key":"20164_CR34","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/s41598-019-48635-x","volume":"9","author":"S Rad Pour","year":"2019","unstructured":"Rad Pour, S. et al. Exhaustion of CD4+ T-cells mediated by the kynurenine pathway in melanoma. Sci. Rep. 9, 12150. https:\/\/doi.org\/10.1038\/s41598-019-48635-x (2019).","journal-title":"Sci. Rep."},{"key":"20164_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636081","volume":"12","author":"M Kim","year":"2021","unstructured":"Kim, M. & Tomek, P. Tryptophan: A rheostat of cancer immune escape mediated by immunosuppressive enzymes IDO1 and TDO. Front. Immunol. 12, 636081. https:\/\/doi.org\/10.3389\/fimmu.2021.636081 (2021).","journal-title":"Front. Immunol."},{"key":"20164_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2021.07.006","volume":"27","author":"N Joisten","year":"2021","unstructured":"Joisten, N., Ruas, J. L., Braidy, N., Guillemin, G. J. & Zimmer, P. The kynurenine pathway in chronic diseases: A compensatory mechanism or a driving force?. Trends Mol. Med. 27, 946\u2013954. https:\/\/doi.org\/10.1016\/j.molmed.2021.07.006 (2021).","journal-title":"Trends Mol. Med."},{"key":"20164_CR37","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","volume":"33","author":"R Lugo-Huitr\u00f3n","year":"2011","unstructured":"Lugo-Huitr\u00f3n, R. et al. On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress. Neurotoxicol. Teratol. 33, 538\u2013547. https:\/\/doi.org\/10.1016\/j.ntt.2011.07.002 (2011).","journal-title":"Neurotoxicol. Teratol."},{"key":"20164_CR38","doi-asserted-by":"publisher","first-page":"117864692097090","DOI":"10.1177\/1178646920970902","volume":"13","author":"A Bhat","year":"2020","unstructured":"Bhat, A., Pires, A. S., Tan, V., Babu Chidambaram, S. & Guillemin, G. J. Effects of sleep deprivation on the tryptophan metabolism. Int. J. Tryptophan. Res. 13, 1178646920970902. https:\/\/doi.org\/10.1177\/1178646920970902 (2020).","journal-title":"Int. J. Tryptophan. Res."},{"key":"20164_CR39","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/j.1742-4658.2012.08493.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin, G. J. Quinolinic acid: Neurotoxicity. Febs j 279, 1355. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08493.x (2012).","journal-title":"Febs j"},{"key":"20164_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-021-02175-2","volume":"18","author":"LM Chen","year":"2021","unstructured":"Chen, L. M. et al. Tryptophan-kynurenine metabolism: A link between the gut and brain for depression in inflammatory bowel disease. J. Neuroinflamm. 18, 135. https:\/\/doi.org\/10.1186\/s12974-021-02175-2 (2021).","journal-title":"J. Neuroinflamm."},{"key":"20164_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/104024","volume":"2013","author":"R Lugo-Huitr\u00f3n","year":"2013","unstructured":"Lugo-Huitr\u00f3n, R. et al. Quinolinic acid: An endogenous neurotoxin with multiple targets. Oxid. Med. Cell Longev. 2013, 104024. https:\/\/doi.org\/10.1155\/2013\/104024 (2013).","journal-title":"Oxid. Med. Cell Longev."},{"key":"20164_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4137\/ijtr.s4294","volume":"3","author":"CK Lim","year":"2010","unstructured":"Lim, C. K., Brew, B. J., Sundaram, G. & Guillemin, G. J. Understanding the roles of the kynurenine pathway in multiple sclerosis progression. Int. J. Tryptophan. Res. 3, 157\u2013167. https:\/\/doi.org\/10.4137\/ijtr.s4294 (2010).","journal-title":"Int. J. Tryptophan. Res."},{"key":"20164_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature06881","volume":"453","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106\u2013109. https:\/\/doi.org\/10.1038\/nature06881 (2008).","journal-title":"Nature"},{"key":"20164_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.phrs.2018.01.022","volume":"133","author":"A Roohbakhsh","year":"2018","unstructured":"Roohbakhsh, A., Shamsizadeh, A., Hayes, A. W., Reiter, R. J. & Karimi, G. Melatonin as an endogenous regulator of diseases: The role of autophagy. Pharmacol. Res. 133, 265\u2013276. https:\/\/doi.org\/10.1016\/j.phrs.2018.01.022 (2018).","journal-title":"Pharmacol. Res."},{"key":"20164_CR45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/cr.2008.63","volume":"18","author":"PP Ho","year":"2008","unstructured":"Ho, P. P. & Steinman, L. The aryl hydrocarbon receptor: A regulator of Th17 and Treg cell development in disease. Cell Res. 18, 605\u2013608. https:\/\/doi.org\/10.1038\/cr.2008.63 (2008).","journal-title":"Cell Res."},{"key":"20164_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/toxsci\/kfx215","volume":"161","author":"AK Ehrlich","year":"2018","unstructured":"Ehrlich, A. K., Pennington, J. M., Bisson, W. H., Kolluri, S. K. & Kerkvliet, N. I. TCDD, FICZ, and other high affinity AhR ligands dose-dependently determine the fate of CD4+ T cell differentiation. Toxicol. Sci. Off. J. Soc. Toxicol. 161, 310\u2013320. https:\/\/doi.org\/10.1093\/toxsci\/kfx215 (2018).","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"20164_CR47","doi-asserted-by":"publisher","first-page":"117864691769173","DOI":"10.1177\/1178646917691738","volume":"10","author":"G Anderson","year":"2017","unstructured":"Anderson, G. & Maes, M. Interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in central nervous system and psychiatric disorders: Role of the aryl hydrocarbon receptor and direct mitochondria regulation. Int. J. Tryptophan. Res. 10, 1178646917691738. https:\/\/doi.org\/10.1177\/1178646917691738 (2017).","journal-title":"Int. J. Tryptophan. Res."},{"key":"20164_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.20110698","volume":"209","author":"E Colombo","year":"2012","unstructured":"Colombo, E. et al. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J. Exp. Med. 209, 521\u2013535. https:\/\/doi.org\/10.1084\/jem.20110698 (2012).","journal-title":"J. Exp. Med."},{"key":"20164_CR49","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1073\/pnas.0912531107","volume":"107","author":"SW Jang","year":"2010","unstructured":"Jang, S. W. et al. N-acetylserotonin activates TrkB receptor in a circadian rhythm. Proc. Natl. Acad. .Sci U S A 107, 3876\u20133881. https:\/\/doi.org\/10.1073\/pnas.0912531107 (2010).","journal-title":"Proc. Natl. Acad. .Sci U S A"},{"key":"20164_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1179\/1351000212y.0000000001","volume":"17","author":"H Massudi","year":"2012","unstructured":"Massudi, H., Grant, R., Guillemin, G. J. & Braidy, N. NAD+ metabolism and oxidative stress: The golden nucleotide on a crown of thorns. Redox. Rep. 17, 28\u201346. https:\/\/doi.org\/10.1179\/1351000212y.0000000001 (2012).","journal-title":"Redox. Rep."},{"key":"20164_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuroscience.2015.03.016","volume":"294","author":"J Majidi-Zolbanin","year":"2015","unstructured":"Majidi-Zolbanin, J., Doosti, M. H., Kosari-Nasab, M. & Salari, A. A. Prenatal maternal immune activation increases anxiety- and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis. Neuroscience 294, 69\u201381. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.03.016 (2015).","journal-title":"Neuroscience"},{"key":"20164_CR52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnagi.2015.00196","volume":"7","author":"VM Golub","year":"2015","unstructured":"Golub, V. M. et al. Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration. Front. Aging Neurosci. 7, 196. https:\/\/doi.org\/10.3389\/fnagi.2015.00196 (2015).","journal-title":"Front. Aging Neurosci."},{"key":"20164_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"20164_CR54","doi-asserted-by":"publisher","first-page":"Research0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, Research0034. https:\/\/doi.org\/10.1186\/gb-2002-3-7-research0034 (2002).","journal-title":"Genome Biol."},{"key":"20164_CR55","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3233\/jad-190049","volume":"69","author":"T Aarons","year":"2019","unstructured":"Aarons, T. et al. Dysregulation of BDNF in prefrontal cortex in Alzheimer\u2019s disease. J. Alzheimers Dis. 69, 1089\u20131097. https:\/\/doi.org\/10.3233\/jad-190049 (2019).","journal-title":"J. Alzheimers Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20164-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T15:17:11Z","timestamp":1664032631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20164-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20164"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20164-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15963"}}